ABOUT THE INSTITUTE

The Pharmaceutical Safety Institute (the Institute) has an 11 member board of directors and an advisory board consisting of approximately 50 healthcare and safety experts from all over the world.

Since the Institute was formed in 2006, our strategic alliances now include esteemed partners such as the Wistar Institute, CDISC, ISOP, ncbio, ACRP, the Hamner Institute, Harris Interactive and other leaders in the healthcare industry.

Building on this foundation of expertise, the Institute continues to develop relationships and encourage the free exchange of ideas to improve global drug safety.

The Institute’s priorities for 2008 are:

 Expand and execute our Consumer Outreach Programs
                                                                    Learn More >>>

 Work with organizations to assess key resource’s understanding of their roles and responsibilities related to safety processes. The assessment will gauge their industry perceptions, ethical considerations as well as how they see themselves supporting a Culture of Safety.       
                                                                    Learn More >>>

 Support and collaborate with other industry and scientific organizations to address safety issues that will collectively make a difference overcoming traditional barriers and “silos”.
                                                                    Learn More >>>